Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could stem cells restore sight in damaged eyes?

NCT ID NCT03011541

Recruiting now Disease control Sponsor: MD Stem Cells Source: ClinicalTrials.gov ↗

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether injecting a person's own bone marrow stem cells into or near the eye can help treat various retinal and optic nerve diseases, including age-related macular degeneration, retinitis pigmentosa, and glaucoma. Participants receive stem cell injections via different routes (behind the eye, under the eye, or into a vein). The goal is to see if these treatments can improve or stabilize vision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

autologous bone marrow derived stem cells

What this could lead to

If it works, this could offer a way to slow vision loss or improve sight in people with retinal or optic nerve damage.

What could go wrong

This is an early study without a control group, so results may be unclear. Risks include injection-related complications and no guarantee of benefit.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

age-related macular degeneration anterior ischemic optic neuropathy autosomal dominant optic atrophy blindness (disorder) cone dystrophy cone-rod dystrophy Doyne honeycomb retinal dystrophy eye disorder Geographic Atrophy glaucoma inherited retinal dystrophy Leber hereditary optic neuropathy macular degeneration neuromyelitis optica night blindness non-arteritic anterior ischemic optic neuropathy optic atrophy optic nerve disorder Optic Nerve Injuries retinal degeneration retinal disorder retinitis pigmentosa Stargardt disease Usher syndrome vision disorder Vision, Low vitamin A deficiency wet macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGE-RELATED MACULAR DEGENERATION BLINDNESS GLAUCOMA LEBER HEREDITARY OPTIC NEUROPATHY MACULAR DEGENERATION MACULOPATHY NONARTERITIC ISCHEMIC OPTIC NEUROPATHY OPTIC ATROPHY OPTIC NERVE DISEASE OPTIC NEUROPATHY RETINA ATROPHY RETINAL DISEASE RETINITIS PIGMENTOSA RETINOPATHY STARGARDT DISEASE VISION LOSS NIGHT VISION LOSS PARTIAL VISION, LOW

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • MD Stem Cells

    RECRUITING

    Westport, Connecticut, 06880, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

    Contact

  • MD Stem Cells

    RECRUITING

    Coral Springs, Florida, 33065, United States

    Contact Phone: •••-•••-••••

  • MD Stem Cells Kobinia Med

    RECRUITING

    Vienna, Austria, 1010, Austria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Saudi-German Hospital

    RECRUITING

    Dubai, United Arab Emirates, 337-1500, United Arab Emirates

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••